TURATO, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 8.670
AS - Asia 4.895
EU - Europa 2.145
SA - Sud America 804
AF - Africa 712
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 67
Totale 17.362
Nazione #
US - Stati Uniti d'America 8.259
SG - Singapore 1.526
CN - Cina 994
HK - Hong Kong 646
VN - Vietnam 530
BR - Brasile 514
IT - Italia 468
FI - Finlandia 206
DE - Germania 193
FR - Francia 182
SE - Svezia 162
BD - Bangladesh 157
IN - India 148
PL - Polonia 129
RU - Federazione Russa 87
GB - Regno Unito 86
CA - Canada 70
IQ - Iraq 69
JP - Giappone 68
NL - Olanda 67
PH - Filippine 66
AR - Argentina 57
TR - Turchia 56
PK - Pakistan 43
AT - Austria 42
MX - Messico 41
UA - Ucraina 41
ZA - Sudafrica 40
EC - Ecuador 38
JO - Giordania 37
KR - Corea 35
PE - Perù 34
CO - Colombia 33
ES - Italia 33
PY - Paraguay 33
SA - Arabia Saudita 32
UZ - Uzbekistan 32
IE - Irlanda 29
EG - Egitto 28
ID - Indonesia 27
VE - Venezuela 27
CY - Cipro 26
MA - Marocco 26
JM - Giamaica 25
LB - Libano 25
MY - Malesia 25
NI - Nicaragua 25
TH - Thailandia 25
AE - Emirati Arabi Uniti 24
AZ - Azerbaigian 24
TW - Taiwan 24
BF - Burkina Faso 23
CM - Camerun 23
GR - Grecia 23
LC - Santa Lucia 23
RO - Romania 23
CD - Congo 22
CG - Congo 22
IL - Israele 22
LA - Repubblica Popolare Democratica del Laos 22
PS - Palestinian Territory 22
BY - Bielorussia 21
CL - Cile 21
HN - Honduras 21
LV - Lettonia 21
SD - Sudan 21
ET - Etiopia 20
KZ - Kazakistan 20
LY - Libia 20
MN - Mongolia 20
MR - Mauritania 20
PA - Panama 20
TN - Tunisia 20
AL - Albania 19
AO - Angola 19
BG - Bulgaria 19
CZ - Repubblica Ceca 19
MG - Madagascar 19
MU - Mauritius 19
PT - Portogallo 19
AD - Andorra 18
AM - Armenia 18
CI - Costa d'Avorio 18
EE - Estonia 18
GA - Gabon 18
GN - Guinea 18
KE - Kenya 18
KG - Kirghizistan 18
ML - Mali 18
SK - Slovacchia (Repubblica Slovacca) 18
SN - Senegal 18
BZ - Belize 17
CH - Svizzera 17
CR - Costa Rica 17
GH - Ghana 17
IR - Iran 17
NO - Norvegia 17
TJ - Tagikistan 17
UY - Uruguay 17
BB - Barbados 16
Totale 16.567
Città #
Singapore 915
Ashburn 885
San Jose 870
Fairfield 864
Woodbridge 596
Hong Kong 568
Chandler 464
Ann Arbor 439
Houston 409
Wilmington 347
Seattle 301
Cambridge 278
Jacksonville 259
Santa Clara 189
Beijing 182
Los Angeles 172
Ho Chi Minh City 158
Boardman 155
Hanoi 143
Princeton 110
San Diego 101
Bytom 97
Helsinki 96
Medford 96
Lauterbourg 89
Padova 87
Nanjing 86
Des Moines 82
Dearborn 69
Council Bluffs 61
Guangzhou 57
Roxbury 55
New York 54
São Paulo 46
Tokyo 36
Changsha 35
Milan 35
Amman 34
Munich 34
Chicago 33
Shenyang 33
Buffalo 28
Dallas 28
Jinan 28
Johannesburg 27
Baghdad 26
Haiphong 26
Hefei 26
Orem 26
Montreal 25
Tashkent 25
Da Nang 24
Lima 24
Nanchang 24
Rome 24
Baku 23
Brooklyn 23
Dublin 23
Frankfurt am Main 23
London 23
Managua 23
Rio de Janeiro 23
Castries 22
Hebei 22
Warsaw 21
Kinshasa 20
Kunming 20
Lahore 20
Nouakchott 20
Panama City 20
Antananarivo 19
Jiaxing 19
Pune 19
Riga 19
Ulan Bator 19
Vienna 19
Vientiane 19
Abidjan 18
Andorra la Vella 18
Libreville 18
Nairobi 18
Nuremberg 18
Amsterdam 17
Atlanta 17
Bamako 17
Conakry 17
Minsk 17
Shanghai 17
Accra 16
Addis Ababa 16
Bishkek 16
Dakar 16
Dushanbe 16
Luanda 16
Lusaka 16
Ouagadougou 16
Turku 16
Brasília 15
Bridgetown 15
Chennai 15
Totale 10.821
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 388
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 360
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 319
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 303
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 283
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 276
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 276
Implicazioni biologiche di SerpinB3 nella fibrosi epatica e nell'epatocarcinoma 269
SERPINB3 induces epithelial-mesenchymal transition. 263
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 254
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 254
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 252
Correction: Corrigendum: SERPINB3 is associated with longer survival in transgenic mice 251
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 250
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 244
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 244
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 242
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 237
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 236
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 234
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 234
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 230
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 226
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 226
Prone Positioning Is Safe and May Reduce the Rate of Intubation in Selected COVID-19 Patients Receiving High-Flow Nasal Oxygen Therapy 225
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 221
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study 221
Hepatic progenitor cells express SerpinB3 220
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 219
Serpinb3 is overexpressed in the liver in presence of iron overload 219
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 215
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 214
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 210
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 210
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 207
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 200
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 197
SERPINB3 is associated with longer survival in transgenic mice. 192
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 181
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. 179
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 175
Hepatic progenitor cells express SerpinB3. 172
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 169
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 161
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 160
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 159
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 156
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 156
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 156
SERPINB3 modulates TGF-beta expression in chronic liver disease. 155
Role of microglial activation via SERPINB3 in experimental acute hepatic encephalopathy 154
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 150
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 148
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3) 145
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 144
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 144
Liver pro-oncogenic potential of SERPINB3. 140
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 138
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 138
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 138
SERPIN-B3 induces HIF2α nuclear translocation in hepatic cancer cells: a paracrine loop able to affect cancer cell behaviour 137
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 135
MicroRNAs and SerpinB3 in hepatocellular carcinoma. 133
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 130
SERPINB3 INCREASES RESISTANCE TO CISPLATIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH INHIBITION OF THE PERMEABILITY TRANSITON PORE 128
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 128
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 126
SERPINB3 è associata a una maggior sopravvivenza in un modello di topo transgenico. 124
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 122
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 118
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 117
HIGH BRAIN EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN ENHANCES BRAIN INJURY IN A TRANSGENIC MOUSE MODEL OF ACUTE LIVER FAILURE: A PILOT STUDY 116
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 115
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 115
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 114
SERPINB3 IS OVEREXPRESSED IN HEPATOBLASTOMA AND CORRELATES WITH MYC SIGNALING AND ANATOMIC TUMOR INVASION 114
SERPIN-B3 as a pro-fibrogenic mediator contributing to chronic liver disease progression 112
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 109
Caratterizzazione biologica e funzionale della nuova isoforma SCCA-PD 109
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 108
MODULATION OF P35 SIGNALING BY SERPINB3 UNDER GENOTOXIC CONDITIONS 108
MODULAZIONE DI P53 E DELLE SUE VIE DI SEGNALE DA PARTE DI SERPINB3 108
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumor? 108
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 106
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 105
RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA 103
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 102
SERPINB3 IS ASSOCIATED TO LONGER SERVIVAL IN MALE TRANSGENIC MICE 102
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 101
DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA 100
SERPINB3 up-regulation in hepatic cancer cells: a critical HIF-2alfa and redox dependent event in liver carcinogenesis. 100
LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA 100
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 97
SERPINB3 DOWNREGULATES THE PROAPOPTOTIC P66SHC PROTEIN IN HUMAN HEPATOMA CELLS 95
SERPINB3 IS ASSOCIATED TO LONGHER SURVIVAL IN MALE TRANSGENIC MICE 94
SerpinB3 drives molecular signatures of worse prognosis and is associated with tumor recurrence in hepatocellular carcinoma 94
ONCOSTATIN M IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND CAN INDUCE EPITHELIAL TO MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS IN HEPATIC CANCER CELLS BY TWO DISTINCT MECHANISMS 92
P66SHC EXPRESSION PROTEIN IS DOWNREGULATED BY SERPINB3 IN HUMAN HEPATOMA CELLS 90
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 90
ONCOSTATIN M, OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA, UP-REGULATES SERPIN-B3 EXPRESSION IN HEPATIC CANCER CELLS 85
Totale 17.129
Categoria #
all - tutte 48.031
article - articoli 36.777
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.070 0 137 141 98 33 68 44 128 37 32 102 250
2022/20231.012 191 93 42 97 173 157 1 75 125 2 43 13
2023/2024495 28 69 63 50 26 70 35 14 17 18 43 62
2024/20252.167 11 128 67 91 245 79 117 180 171 85 446 547
2025/20268.126 328 811 1.033 1.070 707 331 1.256 687 844 458 408 193
2026/2027331 268 63 0 0 0 0 0 0 0 0 0 0
Totale 17.362